1.75
+0.05(+2.94%)
Currency In USD
| Previous Close | 1.7 |
| Open | 1.73 |
| Day High | 1.8 |
| Day Low | 1.65 |
| 52-Week High | 13.43 |
| 52-Week Low | 1.53 |
| Volume | 546,931 |
| Average Volume | 694,977 |
| Market Cap | 65.75M |
| PE | -0.46 |
| EPS | -3.83 |
| Moving Average 50 Days | 2.27 |
| Moving Average 200 Days | 5.56 |
| Change | 0.05 |
If you invested $1000 in Biomea Fusion, Inc. (BMEA) since IPO date, it would be worth $94.09 as of May 09, 2025 at a share price of $1.75. Whereas If you bought $1000 worth of Biomea Fusion, Inc. (BMEA) shares 3 years ago, it would be worth $440.81 as of May 09, 2025 at a share price of $1.75.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights
GlobeNewswire Inc.
May 05, 2025 8:05 PM GMT
Company Announces Strategic Realignment to Focus on Core Programs and Extend Cash Runway Icovamenib progressing toward the next phase of clinical development in insulin deficient type 2 diabetes patients and patients that are currently uncontrolled o
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Apr 01, 2025 8:01 PM GMT
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on March 23, 2025, the compensation committee of
Biomea Fusion Announces Leadership Transition
GlobeNewswire Inc.
Mar 25, 2025 11:00 PM GMT
Board member Mick Hitchcock, named interim CEO replacing Thomas Butler. COO and President Ramses Erdtmann continuing at Biomea in current role. REDWOOD CITY, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” or the “Company